As a result of the FLT3-ITD mutation, MV4-11 AML cells have constitutive activation of FLT3 and its downstream targets, including STAT3 and STAT5, leading to uninhibited cell proliferation and impairment of differentiation and apoptosis [48]. The gene discussed is FLT3; the disease is acute myeloid leukemia.